Loading clinical trials...
Loading clinical trials...
Conditions
Interventions
dydrogesterone 20 mg /d (Duphaston, Abott Healthcare , Egypt)
estradiol valerate 2 mg /d (white tablets of cycloprognova, Bayer Shering, Germany)
Start Date
May 1, 2022
Primary Completion Date
April 1, 2023
Completion Date
May 1, 2023
Last Updated
April 14, 2022
NCT06793098
NCT06793085
NCT07399535
NCT07307677
NCT06800170
NCT07159880
Mohammed Yehia
CONTACT
Lead Sponsor
Sohag University
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions